Summary:
- Researchers at Northwestern University have developed a new drug called NU-9 that targets the toxic proteins associated with Alzheimer's disease.
- NU-9 has shown promise in preventing the buildup of these toxic proteins, which are believed to be a major driver of Alzheimer's disease.
- The drug works by stabilizing the structure of the toxic proteins, preventing them from aggregating and causing damage to brain cells.